Jonathan Massey and Kylie Kim were featured in Law360 coverage of a U.S. Supreme Court matter addressing “skinny label” patent issues, where they represent AbbVie and Bristol Myers Squibb. The case involves questions with significant implications for pharmaceutical patent and regulatory strategy. Read more here.